Novel Cellular Therapies for Hepatocellular Carcinoma

SIMPLE SUMMARY: Hepatocellular carcinoma (HCC) is one of the leading causes of cancer related death worldwide. Most patients present with incurable disease and the prognosis remains poor. Immunotherapy using immune checkpoint inhibitors has become standard of care for advanced disease but only a min...

Descripción completa

Detalles Bibliográficos
Autores principales: Roddy, Harriet, Meyer, Tim, Roddie, Claire
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833505/
https://www.ncbi.nlm.nih.gov/pubmed/35158772
http://dx.doi.org/10.3390/cancers14030504

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833505/
https://www.ncbi.nlm.nih.gov/pubmed/35158772
http://dx.doi.org/10.3390/cancers14030504

Ejemplares similares